| Authors: |
Modi S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. modis@mskcc.org., Jacot W; Medical Oncology Department, Institut du Cancer de Montpellier, Université de Montpellier, INSERM U1194, Montpellier, France., Iwata H; Nagoya City University, Nagoya, Japan., Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Vidal Losada M; Department of Medical Oncology, Hospital Clinic of Barcelona, Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Li W; First Hospital of Jilin University, Changchun, China., Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan., Ueno NT; Translational and Clinical Research Program, University of Hawai'i Cancer Center, Honolulu, HI, USA., Zaman K; Department of Oncology, Lausanne University Hospital CHUV, Lausanne, Switzerland., Prat A; Clinic Barcelona Comprehensive Cancer Center, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Papazisis K; Euromedica General Clinic, Thessaloniki, Greece., Rugo HS; Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Yamashita T; Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan., Harbeck N; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., De Laurentiis M; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Pierga JY; Department of Medical Oncology, Institut Curie, Paris and Université Paris Cité, Paris, France., Wang X; Zhejiang Cancer Hospital, Hangzhou, China., Gombos A; Medical Oncology Department, Institut Jules Bordet, Brussels, Belgium., Tokunaga E; Department of Breast Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan., Orbegoso Aguilar C; Global Oncology R&D, Daiichi Sankyo France SAS, Rueil-Malmaison, France., Yung L; Clinical Development, Daiichi Sankyo Inc., Basking Ridge, NJ, USA., Xiao F; Biostatistics, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA., Cheng Y; Clinical Safety and Pharmacovigilance, Daiichi Sankyo Inc., Basking Ridge, NJ, USA., Cameron D; Edinburgh University Cancer Centre, University of Edinburgh, Edinburgh, UK. |
